Medicaid pricing is setting up a better 2027 for Molina Healthcare
Molina Healthcare is heading into 2027 with a message that has become familiar across payer earnings calls: Medicaid rates may finally begin to catch up with underlying cost pressure. Chief executive Joseph Zubretsky said states are expected to use more recent data in rate calculations, while the behavioral and eligibility effects of new work requirements could also nudge acuity higher. In managed Medicaid, even small shifts in member mix can move margins quickly because the program’s reimbursement structure often lags changes in utilization, diagnosis intensity, and social-risk burden.
The company’s third quarter reflected that pressure. Molina posted profit of $38 million, down from $79 million in the same quarter a year earlier, while revenue fell to $11.1 billion from $11.5 billion. Through the first nine months of 2026, profit totaled $112 million, a steep decline from $632 million in the comparable period of 2025. Those figures show how little room a Medicaid managed care organization has when cost trends outrun rate action, even before the full effects of policy changes start to hit enrollment and risk mix.
Work requirements could reshape enrollment, but the timing will vary by state
Zubretsky said Molina is working closely with state partners as they implement work requirements, which are scheduled to be in place nationwide beginning Jan. 1. The company expects timing to differ across states, and it is already anticipating that disenrollments may be pushed into 2028 in some markets. In practice, that delay matters because membership churn does not always arrive in one clean wave; it often moves through renewal systems, eligibility checks, and administrative processes over several quarters.
Ex parte reviews, hardship exemptions, and self-attestations are part of that operational picture. Those mechanisms can slow the pace at which members lose coverage, and they may also blunt the short-term acuity shift that insurers worry about when healthier enrollees leave first. If that happens, the residual Medicaid population may become sicker and more expensive to cover, even if the overall membership decline is gradual. Molina expects those membership reductions to emerge over time and to create only a minor acuity impact, but the company is clearly positioning itself for a reimbursement reset rather than a sudden shock.
A gradual disenrollment pattern still changes the risk pool.
Rate actions and medical cost trend are doing most of the margin work
Mark Keim, Molina’s chief financial officer, said some states have been willing to consider mid-year rate adjustments. That detail is important because it suggests payers are not waiting for the next annual cycle to absorb rising costs. When state Medicaid programs accept fresher claims and utilization data, rate changes can more quickly reflect the medical severity and service use that plans are already seeing in the field. Zubretsky said Molina expects a medical cost trend between 5.5% and 6% and a flat medical loss ratio in Medicaid for the coming year.
The company’s overall medical loss ratio came in at 92.9% for the quarter, with Medicaid-specific medical loss ratio at 93%. Keim said those results tracked with expectations, and he also said that rate changes helped largely offset the medical cost trend seen in the third quarter. In payer terms, that is a critical distinction: the company is not arguing that utilization has vanished or that cost inflation has disappeared, but rather that pricing action is beginning to catch the trend curve. The gap between a 5.5% to 6% cost trend and a flat Medicaid medical loss ratio is where the 2027 earnings argument is being made.
The economics of Medicaid managed care are unforgiving when rates lag. Even modest changes in inpatient admissions, outpatient intensity, pharmacy utilization, or behavioral health demand can distort the margin profile, especially when the membership base is concentrated in a single line of business. Molina’s quarterly numbers make clear that the company is still absorbing that mismatch, but management is betting that the rate environment will improve enough to support profitability next year.
The quarter shows a thinner cushion while the company waits for policy effects
Membership totaled 4.9 million at quarter end, with about 4.4 million enrolled in Medicaid plans. That concentration explains why the company’s comments on state rate setting and work requirements carry so much weight. When a payer’s membership base is dominated by a public program, federal policy changes and state-level implementation details can reverberate through the balance sheet faster than in more diversified commercial businesses.
Revenue through the first nine months reached $32.8 billion, down from $34.1 billion a year earlier. The company reaffirmed its full-year outlook for earnings of $5.25 per share and revenue of about $42 billion. Those targets suggest management still believes the year can close on a controlled trajectory despite the weaker profit run rate seen so far. Keim described the current operating blocks as positioning the business for profitable growth in 2027, a claim that hinges on the same variables appearing throughout the Medicaid sector: rate adequacy, enrollment mix, and the pace at which policy changes are translated into claims experience.
For now, Molina’s third quarter reads as a transition period rather than a clean inflection point. The company is seeing enough state openness to rate revision to support a constructive 2027 view, but it is still living with a medical loss ratio above 90% and a profit base far below last year’s pace. The open question is not whether Medicaid work rules will matter; it is how quickly state agencies will convert that policy shift into enrollment patterns and reimbursement updates that match the new risk profile.